Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540535 · ClinicalTrials.gov registry record
Dual-Task Cost in Bilateral Hearing Loss
A clinical trial of Healthy Aging and Bilateral Hearing Loss, sponsored by New York University.
- Completed
- Registry status
- 67
- Enrollment target
- 2
- Study locations
NCT05540535: Completed study of Healthy Aging and Bilateral Hearing Loss, sponsored by New York University.
NCT05540535 is a study of Healthy Aging and Bilateral Hearing Loss that has completed, run by New York University. The registered enrollment target is 67 participants, below the 120-participant average among 40 other Healthy Aging trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05540535, a study of Healthy Aging and Bilateral Hearing Loss, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
- 2
- Study locations
Study Summary
The specific aims of the research study are: 1. Compare single-task gait parameters between individuals with hearing loss (HL) and age and education matched controls with normal hearing \[normal vs moderate-profound hearing loss (N=23 for each group)\]. For that we will compare the primary outcome measure, gait speed, between the groups while participants are walking at a comfortable speed for 1 minute. 2. Compare cognitive function between individuals with HL and age and education matched controls. For that we will compare the Neurocognitive Index, derived from a cognitive assessment between groups. 3. Compare the effect of a cognitive task while walking on gait parameters between people with HL and age education matched controls with normal hearing. For that we will compare the primary outcome measure, gait speed, between groups while participants are walking at a comfortable speed and counting backwards \[serial subtraction of 3\] for 1 minute. 4. Explore whether cognitive performance (i.e., the Neurocognitive Index) is correlated with Dual task cost (DTC), a deterioration of gait speed while walking and performing concurrent cognitive task \[serial subtraction of 3\]. The formula to calculate this is the following: DTC = 100 X \[(DT - single task)/ single task\].
Primary Outcome
The gait speed while walking for 1 min will be compared between groups. Normal gait speed will be considered 1.2-1.3 m/sec.
Conditions Studied
Interventions
- OTHER Gait assessment
- OTHER Cognitive assessment
Study Locations (2)
New York
- New York Eye and Ear Infirmary of Mount Sinai - New York
- New York University Physical Therapy Department - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2024-11-22 |
What the finished NCT05540535 record still lists
NCT05540535 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 120-participant average among 40 other Healthy Aging trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Healthy Aging appearing as the primary indexed condition, and to 2 interventions - of which Gait assessment is the first listed.
NCT05540535 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05540535 about?
NCT05540535 is a clinical study titled "Dual-Task Cost in Bilateral Hearing Loss". The specific aims of the research study are: 1. Compare single-task gait parameters between individuals with hearing loss (HL) and age and education matched controls with normal hearing \[normal vs moderate-profound hearing loss (N=23 for each group)\]. For that we will compare the primary outcome ...
What is the current status of trial NCT05540535?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2022-02-01. Estimated completion is 2024-11-22.
What conditions does trial NCT05540535 study?
This clinical trial studies the following conditions: Healthy Aging, Bilateral Hearing Loss.
What interventions are being tested in trial NCT05540535?
The interventions under investigation include: Gait assessment (OTHER), Cognitive assessment (OTHER).
Who is sponsoring clinical trial NCT05540535?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05540535 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05540535's enrollment target sits among peer trials
67 23rd of 40 higher than 18 of 40 other Healthy Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
RECRUITING · NA
-
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
RECRUITING · NA
-
Exercise to Improve Brain Health in Older African Americans
RECRUITING · Phase 2
-
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
RECRUITING · NA
-
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
RECRUITING · NA
-
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI